BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29020310)

  • 1. Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.
    Wolf J; Tang L; Flynn PM; Pui CH; Gaur AH; Sun Y; Inaba H; Stewart T; Hayden RT; Hakim H; Jeha S
    Clin Infect Dis; 2017 Nov; 65(11):1790-1798. PubMed ID: 29020310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
    Alexander S; Fisher BT; Gaur AH; Dvorak CC; Villa Luna D; Dang H; Chen L; Green M; Nieder ML; Fisher B; Bailey LC; Wiernikowski J; Sung L;
    JAMA; 2018 Sep; 320(10):995-1004. PubMed ID: 30208456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic prophylaxis and the gastrointestinal resistome in paediatric patients with acute lymphoblastic leukaemia: a cohort study with metagenomic sequencing analysis.
    Margolis EB; Hakim H; Dallas RH; Allison KJ; Ferrolino J; Sun Y; Pui CH; Yao J; Chang TC; Hayden RT; Jeha S; Tuomanen EI; Tang L; Rosch JW; Wolf J
    Lancet Microbe; 2021 Apr; 2(4):e159-e167. PubMed ID: 34355208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.
    Inaba H; Gaur AH; Cao X; Flynn PM; Pounds SB; Avutu V; Marszal LN; Howard SC; Pui CH; Ribeiro RC; Hayden RT; Rubnitz JE
    Cancer; 2014 Jul; 120(13):1985-92. PubMed ID: 24677028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of levofloxacin as an antibiotic prophylaxis in the induction phase of children newly diagnosed with acute lymphoblastic leukemia: an interim analysis of a randomized, open-label trial in Brazil.
    Dufrayer MC; Rechenmacher C; Meneses CF; Monteiro YMC; Carlesse FAMC; Motta F; Daudt LE; Michalowski MB
    Braz J Infect Dis; 2023; 27(2):102745. PubMed ID: 36750202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the rates of Clostridium difficile and bacteremia after delaying fluoroquinolone prophylaxis from day 0 to day +3 post autologous stem cell transplantation.
    Koseck K; Steinberg A; Caliendo G; Meyer J; Kim SS
    Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28456140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.
    Satlin MJ; Vardhana S; Soave R; Shore TB; Mark TM; Jacobs SE; Walsh TJ; Gergis U
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1808-14. PubMed ID: 26150022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia.
    Karol SE; Sun Y; Tang L; Pui CH; Ferrolino J; Allison KJ; Cross SJ; Evans WE; Crews KR; Jeha S; Wolf J
    Cancer Med; 2020 Sep; 9(18):6550-6555. PubMed ID: 32710497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia.
    Sulis ML; Blonquist TM; Stevenson KE; Hunt SK; Kay-Green S; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JG; Neuberg DS; Sallan SE; Silverman LB
    Pediatr Blood Cancer; 2018 May; 65(5):e26952. PubMed ID: 29319209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness and safety of antibiotic prophylaxis during induction chemotherapy in children with acute leukaemia: a systematic review and meta-analysis.
    Yang M; Lu X; Xin L; Luo J; Diao S; Jia Z; Cheng G; Zeng L; Zhang L
    J Hosp Infect; 2023 Jun; 136():20-29. PubMed ID: 36921630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Use Of Levofloxacin During Induction Of Acute Lymphoblastic Leukaemia In Children-Experience From Pakistan.
    Rehman P; Shaukat Z; Saeed H; Raza A; Anjum S; Wali RM
    J Pak Med Assoc; 2023 Oct; 73(10):2065-2068. PubMed ID: 37876072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
    Drayson MT; Bowcock S; Planche T; Iqbal G; Pratt G; Yong K; Wood J; Raynes K; Higgins H; Dawkins B; Meads D; Hulme CT; Whittaker AC; Hawkey P; Low E; Dunn JA
    Health Technol Assess; 2019 Nov; 23(62):1-94. PubMed ID: 31690402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
    Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A
    Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
    Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
    Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
    Yemm KE; Barreto JN; Mara KC; Dierkhising RA; Gangat N; Tosh PK
    J Antimicrob Chemother; 2018 Jan; 73(1):204-211. PubMed ID: 29040595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levofloxacin prophylaxis for pediatric leukemia patients: Longitudinal follow-up for impact on health care-associated infections.
    Davis A; Stevens AM; Brackett J; Marquez L; Foster CE; Sauer HE; Campbell JR
    Pediatr Blood Cancer; 2022 Jul; 69(7):e29525. PubMed ID: 35029328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.
    De Rosa FG; Motta I; Audisio E; Frairia C; Busca A; Di Perri G; Marmont F
    BMC Infect Dis; 2013 Dec; 13():563. PubMed ID: 24289496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posaconazole and fluconazole prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia.
    Zhang T; Bai J; Huang M; Li R; Liu Y; Liu A; Liu J
    J Microbiol Immunol Infect; 2021 Dec; 54(6):1139-1146. PubMed ID: 32828790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions.
    Lee SSF; Fulford AE; Quinn MA; Seabrook J; Rajakumar I
    Support Care Cancer; 2018 May; 26(5):1499-1504. PubMed ID: 29170868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients.
    Gardner JC; Courter JD; Dandoy CE; Davies SM; Teusink-Cross A
    Transplant Cell Ther; 2022 Mar; 28(3):167.e1-167.e5. PubMed ID: 34875405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.